Clinical Trial Update: A Clinical Trial to Investigate the Long-term Safety and Tolerability, Efficacy, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of ARGX-117 in Adults With Multifocal Motor Neuropathy [Phase 2]

View source ↗

Summary

This update describes a Phase 2 trial of ARGX-117 evaluating long-term safety, tolerability, efficacy, pharmacodynamics, pharmacokinetics, and immunogenicity in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multifocal Motor Neuropathy

Drugs mentioned

• ARGX-117

Snippet

Sponsor: argenx | Conditions: Multifocal Motor Neuropathy (MMN) | Phase 2 | Status: ACTIVE_NOT_RECRUITING